Children's Health Defense Moderna halted its Phase 1 trial of an mRNA vaccine to treat the Epstein-Barr virus after a single suspected case of myocarditis in an adolescent, raising questions about the heart-damaging technology used in all mRNA vaccines, according to a report by Alex Berenson.
Investigators halted a Moderna trial of a new mRNA vaccine for Epstein-Barr virus (EBV) after a participant developed suspected myocarditis, according to independent journalist Alex Berenson.
Moderna paused the Phase 1 âEclipseâ trial following âan urgent communicationâ from the company overseeing the trial stating that the adverse event ânecessitates an immediate suspension of all dosing for ALL adolescents,â Berenson reported.
A person not employed by Moderna provided the communication to Berenson, a former New York Times reporter and author of 13 books.
Read Full Article Here…(childrenshealthdefense.org)
Home | Caravan to Midnight (zutalk.com)
Live Stream + Chat (zutalk.com)
